These results reveal a critical link between mitochondrial dynamics and lipid metabolic reprogramming in ovarian cancer, with MIEF2‐mediated activation of the PI3K/AKT/mTOR/SREBP axis driving tumor aggressiveness. The gene discussed is AKT1; the disease is neoplasm.